Category: Rescue
Comprehensive and Flexible Partnership to Support Rescue Study A biotech company new to clinical research with an asset early in its development lifecycle became a long-term partner with Catalyst Flex. For years, Catalyst has worked alongside to help achieve the client’s goals for a single asset for the first bladder cancer therapy on the horizon in the past 20 years. Read Now 
Focused Monitoring Support for Rare Disease Study A small biotech needed functional support for a Phase III rare disease study. Although a contract
existed between the biotech and a clinical research organization (CRO), the study timelines and budget
had slipped. The biotech hired Catalyst Flex to reverse that trend and ultimately saved ~$1 million. Read Now 
Catalyst Oncology FIH Rescue Study A clinical-stage biotech company with a critical startup milestone Catalyst Oncology transitioned full-service work from Read Now 
Global Full-service Phase III Ovarian Cancer Study Catalyst Oncology succeeds in delivering for late clinical-stage oncology biotech. While the biotech had experience Read Now